Aizon Secures $20M in Series C Funding Led by NewVale Capital to Enhance Pharma Manufacturing Outcomes streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
SAN FRANCISCO (BUSINESS WIRE) #AI Aizon (Bigfinite Inc.), the leader in compliant AI for Biopharma Manufacturing, announced today that John Vitalie will step down as CEO of the company effective as of July 22nd. He will be succeeded by Pep Gubau, founder and CTO, and Executive Chairman of the company.John has le.
Aizon Launches GxP AI Bioreactor Application For The Pharma Industry To Scale Manufacturing & Quality
SAN FRANCISCO (BUSINESS WIRE)
Aizon launches its Bioreactor Application, the pharma industry’s first predictive analysis and deep knowledge management application. The Aizon Bioreactor Application adds the bioreactor process to the “Smart Manufacturing” transformation that is accelerating across the Pharma and Biotech industry. Aizon is uniquely able to achieve GxP compliance and provide an audit trail from the start of the process. The turnkey application allows pharmaceutical and biotech companies to leverage rich datasets generated during upstream manufacturing to detect and accurately predict deviations and outcomes potentially leading to hundreds of millions of dollars in cost savings, reduced risk, and additional revenue upside.